Search results for: 'CleanCap® Cas9 mRNA'

Cat #: L-8106

Cat #: L-7606

Cat #: L-7207

Cat #: L-7206

CRISPR-based genome editing tools show tremendous potential as therapeutic agents for the treatment of genetic diseases and viral infections, as discussed in previous  Zone   blogs  and the  June 2021 TriLink Research Spotlight  titled,  A Novel Base-Editing Strategy Promises to Treat Sickle Cell Disease . Nevertheless, safe and efficient delivery of CRISPR tools to target tissues continues to attract growing attention (see Chart). A wide variety of technical approaches are being exp...